Loading...
XETR
RHK
Market cap987mUSD
May 30, Last price  
13.00EUR
1D
0.78%
1Q
-12.75%
Jan 2017
-49.34%
Name

Rhoen Klinikum AG

Chart & Performance

D1W1MN
P/E
20.07
P/S
0.55
EPS
0.65
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
4.12%
Revenues
1.60b
-8.02%
1,415,788,0001,933,043,0002,024,754,0002,130,277,0002,320,089,0002,550,384,0002,629,148,0002,864,909,0003,013,835,0001,510,519,0001,108,189,0001,176,349,0001,211,077,0001,232,908,0001,303,898,0001,360,159,0001,402,010,0001,446,086,0001,734,725,0001,595,619,000
Net income
43m
+11.98%
83,680,000105,200,000106,292,000122,644,000131,652,000145,069,000156,114,00089,685,00086,648,0001,225,711,00085,381,00056,430,00035,150,00048,993,00043,277,0002,463,00028,295,00025,144,00038,712,00043,351,000
CFO
128m
+17.06%
186,400,000235,600,000182,000,000187,000,000212,500,000221,500,000236,200,000139,100,000210,400,00049,200,00070,200,000109,100,00080,300,00049,500,00047,300,000113,300,00097,500,00041,300,000109,000,000127,600,000
Dividend
Jun 08, 20230.15 EUR/sh
Earnings
Aug 06, 2025

Profile

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. It operates eight hospitals and 5,420 beds/places at five medical sites. The company is based in Bad Neustadt an der Saale, Germany.
URL
https://www.rhoen-klinikum-ag.com/
IPO date
Nov 27, 1989
Employees
18,062
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,595,619
-8.02%
1,734,725
19.96%
1,446,086
3.14%
Cost of revenue
1,493,197
1,536,650
468,262
Unusual Expense (Income)
NOPBT
102,422
198,075
977,824
NOPBT Margin
6.42%
11.42%
67.62%
Operating Taxes
10,997
7,562
6,689
Tax Rate
10.74%
3.82%
0.68%
NOPAT
91,425
190,513
971,135
Net income
43,351
11.98%
38,712
53.96%
25,144
-11.14%
Dividends
(10,000)
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
34,600
3,661
10,900
Long-term debt
121,800
153,276
155,800
Deferred revenue
24
(8,600)
Other long-term liabilities
5,663
8,360
15,128
Net debt
(137,407)
(199,182)
75,553
Cash flow
Cash from operating activities
127,600
109,000
41,300
CAPEX
(70,400)
(62,800)
(58,200)
Cash from investing activities
(50,400)
40,900
(86,200)
Cash from financing activities
(3,300)
(21,200)
(4,100)
FCF
109,065
200,993
939,892
Balance
Cash
426,664
342,842
304,934
Long term investments
(132,857)
13,277
(213,787)
Excess cash
214,026
269,383
18,843
Stockholders' equity
197,448
706,134
855,509
Invested Capital
1,283,787
1,169,040
1,372,513
ROIC
7.45%
14.99%
73.09%
ROCE
6.89%
13.77%
69.85%
EV
Common stock shares outstanding
66,938
66,938
66,938
Price
Market cap
EV
EBITDA
165,022
263,675
1,047,424
EV/EBITDA
Interest
3,400
3,700
4,100
Interest/NOPBT
3.32%
1.87%
0.42%